| CXHL1300489 | 对甲苯磺酸拉帕替尼片 | lapatinib ditosylate | Tablet | Chemical Drugs(3.1) | New Drug Application | 2013-06-28 | 四川科伦药物研究院有限公司 | Sichuan Kelun Pharmacy Institute Co Ltd | Certificate Issued | 2015-10-13 | view |
| JXHL0700314 | 甲苯磺酸拉帕替尼片 | lapatinib ditosylate | Tablet | Chemical Drugs(3.1) | Import Drug Application | 2007-11-06 | | Glaxo Group Ltd | Certificate Issued | 2013-01-29 | view |
| JYHB1700919 | 甲苯磺酸拉帕替尼片 | lapatinib ditosylate | Tablet | Chemical Drugs | Supplementary Application | 2017-07-01 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2017-11-28 | view |
| JYHB1900595 | 甲苯磺酸拉帕替尼片 | lapatinib ditosylate | Tablet | Chemical Drugs | Supplementary Application | 2019-06-12 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2019-11-26 | view |
| JXHL1300496 | 甲苯磺酸拉帕替尼片 | lapatinib ditosylate | Tablet | Chemical Drugs | Import Drug Application | 2014-01-03 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2014-11-24 | view |
| JYHF1700133 | 甲苯磺酸拉帕替尼片 | lapatinib ditosylate | Tablet | Chemical Drugs | Supplementary Application | 2018-01-10 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2018-02-23 | view |
| JYHB2100135 | 甲苯磺酸拉帕替尼片 | lapatinib ditosylate | Tablet | Chemical Drugs | Supplementary Application | 2021-02-09 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | In Review | 2021-02-08 | view |
| CYHS1400699 | 甲苯磺酸拉帕替尼片 | lapatinib ditosylate | Tablet | Chemical Drugs(6) | Generic Drug | 2014-11-15 | 山东罗欣药业股份有限公司 | Shandong Luoxin Pharmaceutical Group STOCK Co Ltd | Certificate Issued | 2016-02-29 | view |
| JYHB1900596 | 甲苯磺酸拉帕替尼片 | lapatinib ditosylate | Tablet | Chemical Drugs | Supplementary Application | 2019-05-20 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2019-11-26 | view |
| CYHS1300741 | 甲苯磺酸拉帕替尼片 | lapatinib ditosylate | Tablet | Chemical Drugs(6) | Generic Drug | 2013-09-02 | 齐鲁制药（海南）有限公司 | Qilu Pharmaceutical (Hainan) Co Ltd | Certificate Issued | 2016-01-14 | view |
| JYHZ1700087 | 甲苯磺酸拉帕替尼片 | lapatinib ditosylate | Tablet | Chemical Drugs | License Renew | 2017-10-01 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2017-11-13 | view |
| JYHB2100134 | 甲苯磺酸拉帕替尼片 | lapatinib ditosylate | Tablet | Chemical Drugs | Supplementary Application | 2021-02-09 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | In Review | 2021-02-08 | view |
| JYHB1800497 | 甲苯磺酸拉帕替尼片 | lapatinib ditosylate | Tablet | Chemical Drugs | Supplementary Application | 2018-05-15 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2019-03-26 | view |
| JYHZ2100512 | 甲苯磺酸拉帕替尼片 | lapatinib ditosylate | Tablet | Chemical Drugs | License Renew | 2021-04-15 | | | | | view |
| JYHZ1700088 | 甲苯磺酸拉帕替尼片 | lapatinib ditosylate | Tablet | Chemical Drugs | License Renew | 2017-10-01 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2017-11-13 | view |
| JYHB2002400 | 甲苯磺酸拉帕替尼片 | lapatinib ditosylate | Tablet | Chemical Drugs | Supplementary Application | 2020-11-26 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Filed | 2020-12-09 | view |
| CYHS1400812 | 甲苯磺酸拉帕替尼片 | lapatinib ditosylate | Tablet | Chemical Drugs(6) | Generic Drug | 2014-09-18 | 正大天晴药业集团股份有限公司 | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | Certificate Issued | 2016-02-03 | view |
| JYHZ2100511 | 甲苯磺酸拉帕替尼片 | lapatinib ditosylate | Tablet | Chemical Drugs | License Renew | 2021-04-15 | | | | | view |
| JYHB1300502 | 甲苯磺酸拉帕替尼片 | lapatinib ditosylate | Tablet | Chemical Drugs | Supplementary Application | 2013-04-10 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2014-02-24 | view |
| JYHB1700918 | 甲苯磺酸拉帕替尼片 | lapatinib ditosylate | Tablet | Chemical Drugs | Supplementary Application | 2017-07-24 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2017-12-21 | view |
